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Growth factorHeparan sulfate proteoglycans (HSPGs) are found in the basementmembrane and at the cell-surfacewhere they
modulate the binding and activity of a variety of growth factors and other molecules. Most of the functions of
HSPGs are mediated by the variable sulfated glycosaminoglycan (GAG) chains attached to a core protein.
Sulfation of the GAG chain is key as evidenced by the renal agenesis phenotype in mice deﬁcient in the HS
biosynthetic enzyme, heparan sulfate 2-O sulfotransferase (Hs2st; an enzyme which catalyzes the 2-O-sulfation
of uronic acids in heparan sulfate).Wehave recently demonstrated that this phenotype is likely due to a defect in
induction of themetanephric mesenchyme (MM), which along with the ureteric bud (UB), is responsible for the
mutually inductive interactions in the developing kidney (Shah et al., 2010). Here,we sought to elucidate the role
of variableHS sulfation inUBbranchingmorphogenesis, particularly the role of 6-O sulfation. EndogenousHSwas
localized along the length of the UB suggesting a role in limiting growth factors and other molecules to speciﬁc
regions of the UB. Treatment of cultures ofwhole embryonic kidneywith variably desulfatedheparin compounds
indicated a requirement of 6O-sulfation in the growth and branching of the UB. In support of this notion,
branchingmorphogenesis of the isolated UBwas found to bemore sensitive to the HS 6-O sulfationmodiﬁcation
when compared to the 2-O sulfationmodiﬁcation. In addition, a variety of knownUBbranchingmorphogens (i.e.,
pleiotrophin, heregulin, FGF1 and GDNF) were found to have a higher afﬁnity for 6-O sulfated heparin providing
additional support for the notion that this HSmodiﬁcation is important for robust UB branching morphogenesis.
Taken together with earlier studies, these ﬁndings suggest a general mechanism for spatio-temporal HS
regulation of growth factor activity along the branching UB and in the developingMMand support the view that
speciﬁc growth factor-HSPG interactions establishmorphogengradients and function asdevelopmental switches
during the stages of epithelial organogenesis (Shah et al., 2004).olecular Medicine, Pediatrics,
500 Gilman Drive, La Jolla, CA
cology and Toxicology, Kyorin
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Kidney development is initiated when the ureteric bud (UB) forms
as an outpouching of the Wolfﬁan duct (WD) in response to signals
emanating from the adjacent metanephric mesenchyme (MM). The
UB then invades theMMwhere it undergoesmultiple iterative rounds
of dichotomous branching morphogenesis to form the tree-like
collecting system of the urinary tract. Since nephrons, derived fromthe MM, are induced at UB tips, UB branching morphogenesis is not
only a primary determinant of ﬁnal nephron number (Nigam, 1995;
Sampogna and Nigam, 2004; Shah et al., 2004; Nigam and Shah,
2009), but also the scaffolding for ﬁnal kidney architecture (al-Awqati
and Goldberg, 1998; Meyer et al., 2004). Since the functions of the
adult kidney are critically dependent upon the number and
arrangement of nephrons, factors that control UB branching morpho-
genesis can ultimately viewed as modulators of susceptibility to
diseases such as hypertension (Brenner et al., 1988) and chronic
kidney disease (Brenner and Milford, 1993), as well as congenital
kidney diseases such as multicystic dysplastic kidney or congenital
hydronephrosis.
Multiple growth factors have been identiﬁed as modulators of UB
branching and architecture. Of these, some of the most prominent
members have belonged to the FGF and TGFβ families (Bush et al.,
20 M.M. Shah et al. / Developmental Biology 356 (2011) 19–272004; Qiao et al., 1999b, 2001; Sakurai et al., 1997; Santos et al., 1993).
FGFs have been shown to affect the formation of UB tips and stalks,
and signaling through a variety of FGF receptors has been shown to
play a role in UB branching and stromal mesenchymal patterning
(Poladia et al., 2006; Qiao et al., 2001; Zhao et al., 2004). Similarly,
members of the TGFβ superfamily have been shown to play a role in
UB patterning, limit the extent of UB branching and may function as a
stop signal at a variety of major developmental stages (Bush et al.,
2004). While it is clear that these factors play a role in these various
morphogenetic processes (e.g., initiation of branching, rapid branch-
ing, patterning, and the cessation of branching), how they exert these
spatiotemporal effects remains undeﬁned.
Nevertheless, heparan sulfate proteoglycans (HSPGs) are believed
to play a key role in modulating the effects of growth factors based on
their ability to bind to and regulate their actions either by
1) presenting the growth factor to its receptor, 2) acting as a co-
receptor, 3) concentrating or sequestering the growth factors, and/or
4) negatively modulating growth factor signaling. HSPGs are
composed of a core protein to which are attached heparan sulfate
(HS) side-chains comprised of highly complex glycosaminoglycan
(GAG) chains with a variable number of disaccharide repeats sulfated
at a variety of positions (Esko and Lindahl, 2001). Sulfation of the
disaccharide, which is catalyzed by a number of enzymes (i.e.,
members of the N-deacetylase-N-sulfotransferase (Ndst) family, the
uronyl C5-epimerase (Hsglce) and 2-O-sulfotransferase (Hs2st), the
glucosaminyl 6-O-sulfotransferases (Hs6st) and 3-O-sulfotransferases
(Hs3st)) (reviewed in Esko and Lindahl, (2001)), generally occurs
sequentially (i.e., Ndst→HsGlce→Hs2st→Hs6st→Hs3st). However
since some reactions do not go to completion, unique patterns of
modiﬁed sulfate residues are created in sections of the chains. It is
believed that both the density and pattern of sulfation are important
determinants of the HS-growth factor interactions (Deakin et al., 2009;
Kreuger et al., 2006; Shah et al., 2010; Sugaya et al., 2008). For example,
in the kidney, knockout of the HS biosynthetic enzyme, heparan sulfate
2-O sulfotransferase (Hs2st) results in a severe kidney phenotype
(Bullock et al., 1998). Despite compensation in sulfation at other
positions, speciﬁcally the 6-O position (Wilson et al., 2002), that
preserves overall charge, knockout of Hs2st results in renal agenesis
(Bullock et al., 1998) suggesting that sulfation at this position is critical
in the modulation of the activity of one or more key growth factors
involved in kidney development (Merry et al., 2001). We have recently
shown that HS modiﬁcations by Hs2st, previously thought to be
important for binding growth factors involved in UB branching, actually
inﬂuences the binding of factors more likely involved in MM induction
and differentiation (Shah et al., 2010). While there is ample evidence
that UB branching is modulated by growth factors that bind HS, this
raises the following question: Are these UB branch modulating growth
factors similarly dependent upon a speciﬁc HS sulfation pattern?
Here we sought to further examine this question and to deﬁne the
role that HS plays in growth factor-mediated UB branching morpho-
genesis. Since knockouts ofHs3st1 andHs3st2 do not have any apparent
kidney defects (HajMohammadi et al., 2003) and an increase in 6-O
sulfation has been reported in the Hs2st knockout that has defective
nephrogenesis (Wilson et al., 2002), we decided to investigate the role
of 6-O sulfation in kidney development. We found that endogenous HS
is found all along theUBwith the potential to localize exogenous growth
factors to speciﬁc regions of the UB (tip vs. stalk) and that isolated UB
branching is more sensitive to the HS 6-O sulfation modiﬁcation. We
also show that a variety of known UB branching morphogens
demonstrate a higher afﬁnity to heparin 6-O sulfation suggesting that
this modiﬁcation may be necessary for robust UB branching. These
studies outline a general mechanism for spatio-temporal HS regulation
of growth factor activity along the branchingUB and are consistentwith
the view that growth factor-HSPG interactions may function in
switching between stages of organogenesis (Shah et al., 2004; Nigam
and Shah, 2009).Materials and methods
Materials
Heparin and desulfated heparin compounds (2-O-desulfated
heparin and 6-Odesulfated heparin) were obtained from Neoparin
(Alameda, CA). Tissue culture media were obtained from GIBCO-BRL
(Grand Island, NY) and fetal calf serum obtained from Biowhittaker
(East Rutherford, NJ). Transwell ﬁlters (0.4-μm pore size) were
obtained from Costar (Corning, NY). Growth factor-reduced Matrigel
was obtained from Becton Dickinson (Franklin Lakes, NJ). Recombi-
nant rat glial-cell-line-derived neurotrophic factor (GDNF), FGF1,
FGF2 and recombinant mouse FGFR2IIIb-human Fc chimera were
from R&D systems (Minneapolis, MN). FITC-conjugated Dolichos
biﬂorus lectin (DB) was obtained from Vector Laboratories (Burlin-
game, CA). The primary antibody against E-cadherin [mouse mono-
clonal, 1:100] was from BD Transduction Laboratories (San Jose, CA);
secondary antibodies were from Jackson Immunoresearch Laborato-
ries (West Grove, PA). All other reagents and chemicals, unless
otherwise indicated, were from Sigma (St. Louis, MO). Antibodies
against pleiotrophin and heregulin were purchased from R&D systems
(Minneapolis, MN), antibodies against FGF1 and GDNF were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).Culture of isolated embryonic kidneys
Embryonic kidneys were isolated from gestational day 13.5
(E13.5) Sprague–Dawley rat embryos and cultured on top of
Transwell ﬁlters as previously described (Barasch et al., 1997; Bush
et al., 2004; Karihaloo et al., 2001; Meyer et al., 2006; Qiao et al.,
1999a, 2001; Sakurai et al., 2001, 2005; Shah et al., 2009, 2010; Zent
et al., 2001).Ligand and carbohydrate engagement (LACE) assay
A modiﬁcation of the LACE assay (Allen and Rapraeger, 2003) was
performed as previously described (Patel et al., 2007). Brieﬂy, to probe
the ability of endogenous HS to bind growth factor (Fig. 1), embryonic
kidneys isolated at e13.5 and cultured for 6–7 days in normal growth
media were treated for 3 h with 0.005 U/ml heparinase III (Sigma) at
37 °C and then washed with PBST. The kidneys were then blocked
overnight at 4 °C followed by incubation with 50 nM recombinant
mouse FGFR2IIIb-human Fc chimera with or without 50 nM FGF1. The
FGFR-FGF-HS high afﬁnity complex was detected using an anti-
human Fc (Invitrogen; Carlsbad, CA).Growth of whole embryonic kidneys in presence of variably sulfated
heparin
E13.5 isolated kidneyswere cultured for 4–6 days in the absence or
presence of varying concentrations of heparin, de2OS-heparin or
de6OS-heparin as previously described (Shah et al., 2010).Isolation and culture of the UB in the presence of variably sulfated
heparin
UBs were isolated from E13.5 embryonic rat kidneys and cultured
as previously described (Bush et al., 2004; Karihaloo et al., 2001; Qiao
et al., 1999a, 2001; Sakurai et al., 2001, 2005). UBs were cultured for
6–7 days in the absence or presence of varying concentrations of
either heparin or the desulfated heparin compounds as previously
described (Shah et al., 2010).
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Fig. 1. Localization of endogenous heparan sulfate in the embryonic kidney utilizing a
modiﬁed in situ ligand and carbohydrate engagement (LACE) assay. Embryonic kidneys
isolated at e13.5 and cultured for 6–7 days were probed for the presence of endogenous
HS using FGF1-recombinant huFGFR2IIIb binding as a probe. Recombinant huFGFR2IIIb
binding occurs at minimal levels in the presence (A) and absence (B; treatment with
heparitinase) of endogenous HS. Binding of recombinant huFGFR2IIIb is signiﬁcantly
increased in the presence of FGF1 in the presence of endogenous HS (C) but is
speciﬁcally diminished at UB tips in the absence of endogenous HS (D; treatment with
heparitinase). FGFR (green) and D. biﬂorus (red); (A,B 10×; C,D 40×).
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fractions
6OS-depletedheparin and2OS-depletedheparinwere conjugated to
Sepharose beads as per instructions for EHS-Sepharose column (GE
Healthcare). The efﬁciency of heparinoid conjugation was assessed via
the carbazole method of Dische (Dische, 1947), with D-glucuronic acid
as standard, and found to be similar for both 6OS-depleted and 2OS-
depleted heparin. Hi-trap heparin (1 ml) column (GE healthcare)
was used as unmodiﬁed heparin column. An EHS Sepharose column
without ligand conjugation was used as a negative control. A
metanephric mesenchyme conditioned media, BSN (Barros-Sakurai-
Nigam)-CM was fractionated across the columns as previously
described (Bush et al., 2004; Sakurai et al., 2001, 2005). The buffer of
the BSN-CMwas changed to 50 mMHEPES pH 7.2 and an equal amount
was applied to each heparinoid column. Bound proteins were eluted by
increasing NaCl (0–2 M) concentration. 1 ml fractions were collected
followed by buffer change to DMEM/F12 by Ultra-Free centrifugal ﬁlter
with molecular weight cutoff of 5000 Da (Millipore).
Isolation and culture of the UB in the presence of eluted puriﬁed fractions
of BSN-CM
The morphogenetic activity of each puriﬁed fraction of BSN-CM
was assayed using the isolated UB culture. Isolated E13.5 UBs were
suspended within an extracellular matrix gel and cultured on top of
Transwell ﬁlters placed within the individual wells of a 24-well tissue
culture dish as previously described (Bush et al., 2004; Karihaloo et al.,
2001; Qiao et al., 1999a, 2001; Sakurai et al., 2001, 2005). 400 μl of
either whole BSN-CM, puriﬁed fractions of BSN-CM, or DMEM/F12
supplemented with ﬁbroblast growth factor 1 (FGF1; 250 ng/ml; R&D
Systems), rat recombinant GDNF (125 ng/ml; R&D Systems) and 10%FCS was applied to the bottom of each well and the UB was cultured
for 4–6 days.
Immunoblot analysis of puriﬁed fractions
15 μl of each puriﬁed fraction of BSN-CM was also subjected to
SDS-PAGE followed by Western blot analysis for the presence of
various factors previously found to be important in UB growth and
branching (Sakurai et al., 2001, 2005). Assessment of binding afﬁnity
for puriﬁed recombinant growth factors (GDNF and FGF1) was carried
out by dissolving growth factors in 50 mM HEPES, pH 7.2 buffer to a
concentration of 200 ng/ml and 200 μl of the mixture was applied to
the heparin and desulfated heparin columns. Elution and fractionation
were performed as in the case with BSN conditioned media.
Immunocytochemistry and confocal analysis
Isolated UB grown in extracellular matrix gels or cultured
embryonic kidneys were ﬁxed in 4% paraformaldehyde (EM Sciences,
Fort Washington, PA) for 30 min at room temperature and then
washed with PBS. UBs were dissected from the Transwell insert and
excess extracellular matrix gel was removed. Immunocytochemistry
was performed as previously described (Meyer et al., 2004). Brieﬂy,
the UBs were equilibrated in quenching solution (20 mM glycine,
75 mM NH4Cl, 0.1% Triton X-100, in PBS) for 30 min at room
temperature followed by incubation in blocking buffer (0.05% Triton
X-100, 0.75% Fish gelatin in PBS) for 1 h at 4 °C before antibody
staining. Whole cultured kidneys were incubated in blocking buffer
for 1 h at room temperature after ﬁxation. Staining was then
performed. Specimens were examined by scanning laser confocal
microscopy (Zeiss LSM-510). Images were processed with Photoshop
software (Adobe, San Jose, CA).
Statistics
Embryonic kidneys and isolated UBs were grown as described in
the presence of heparin, 2OS-depleted heparin, or 6OS-depleted
heparin. Embryonic kidneys and isolated UBs were ﬁxed at day 3 and
day 7, respectively, and stained with Dolichos biﬂorus lectin to
delineate UB tips. Each assay was performed in at least triplicate
and data are presented as mean values±S.D. The Anova single factor
test was applied to data from the experiments. A p value of b0.05 was
accepted to indicate statistical signiﬁcance.
Results
We have previously hypothesized that HS acts as a “switch” to
modulate growth factor activity in the kidney and perhaps regulate
branching morphogenesis of the epithelial ureteric bud (UB) (Bush
et al., 2004; Nigam and Shah, 2009; Sampogna and Nigam, 2004; Shah
et al., 2004; Steer et al., 2004). In other words, speciﬁcally sulfated HS
expressed in distinct areas of the UB potentially control/modulate
growth factor activity (either positively or negatively) and thus may
act as a regulatory mechanism for speciﬁc morphogenetic events
during the stages of kidney development.
Heparan sulfate along the branching UB acts to localize growth factor
binding
Taking advantage of the requirement for HS in the formation of high
afﬁnity ﬁbroblast growth factor (FGF)/FGF receptor complexes (Ornitiz,
2000), the endogenous HS in the developing rodent kidney was
evaluated utilizing a modiﬁed in situ whole mount ligand and
carbohydrate engagement (LACE) assay (Allen and Rapraeger, 2003;
Pan et al., 2006, 2008; Patel et al., 2007; Qu et al., 2011). In these
experiments the binding of the FGF-FGFR complex with HS was
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Fig. 2. Effect of 6OS-depleted heparin on embryonic kidney branching morphogenesis.
A: Graphical analysis of the average number of UB tips as a percentage of control when
cultured in the presence of varying concentrations of heparin or 6OS-depleted heparin.
Mean±SD, nN3, *pb0.05 compared to control. B–D: Phase contrast photomicrographs
of whole embryonic kidneys cultured for 4–6 days in the absence (B) or presence of
100 μg/ml of either de6OS-heparin (C) or heparin (D). Even at higher concentrations,
compared to heparin-treated kidneys (C), UB architecture is largely preserved despite
further reduction in UB tip number in the presence of de6OS (B); inset is a confocal
image of the embryonic kidney in the presence of de6OS-heparin; open arrow points to
UB tip and closed arrow points to UB stalk (D. biﬂorus lectin (green) and E-cadherin
(red)). Photomicrographs taken at 10× magniﬁcation.
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FGF would have sufﬁced; FGF1 is often utilized to the promiscuous
nature of its binding to FGFRs), a human FGFR-FC chimera (FGFR2IIIb-
human Fc chimera) and a FITC-conjugated anti-human Fc IgG antibody.
The FGF1-FGFR-Fc chimera serves as theHSbinding ligandwhich,when
probedwith the FITC-conjugated anti-human Fc antibody, allows direct
visualization of the distribution of endogenous HS in the embryonic
rodent kidney (Fig. 1). As a control for non-speciﬁc binding, cultured
kidneys were incubated with the FGFR-Fc chimera in the absence of the
FGF. The FGFR-Fc chimera displayed some binding to the kidney which
was completely eliminated in the presence of heparitinase (an enzyme
which cleaves heparan sulfate chains) demonstrating the HS depen-
dence of the observed binding (Figs. 1A and B). Incubation with both
FGF1 and the FGFr-Fc chimera revealed the presence of endogenous HS
throughout the embryonic kidney particularly along the UB basement
membrane where it appeared to be localized to epithelial cell
membranes (Fig. 1C). Following treatment with heparitinase, the HS-
FGF-FGFR signal was signiﬁcantly diminished overall with an almost
complete loss around the UB tips (Fig. 1D). Thus there appears to be a
close association of HS and the epithelial UB, which taken together with
the fact that HS plays a crucial role in cell signaling and tissue
development through its interactions with a wide variety of growth
factors and morphogens (Thompson et al., 2010), provides support for
the notion that HS plays a role in kidney development perhaps by
participating in the localization of growth factor activity to distinct
regions of the branching UB.
Growth factor stimulated UB branching in organ culture demonstrates
greater sensitivity to HS 6-O sulfation over HS 2-O sulfation
Recently, we showed that the 2-O sulfation of HS 2-O is critical for
mesenchymal induction, a key step in early kidney development
(Shah et al., 2010). In addition, we found that growth factors that
modulated UB branching did not appear as sensitive to the 2-O
modiﬁcation as those modulatingmesenchymal induction, raising the
likelihood sulfation modiﬁcations other than 2-O sulfation might be
important in UB branching morphogenesis. Since a number of lines of
evidence implicated 6-O sulfation as a likely candidate, including 1)
the apparently normal development of mice bearing null mutations in
3-O sulfotransferases (HajMohammadi et al., 2003), 2) the observed
increase in 6-O sulfation displayed in 2-O sulfotranferase mutantmice
(Wilson et al., 2002) and, 3) many lines of biochemical data which
suggest that growth factors that are involved in UB branching are
sensitive to 6-O sulfation modiﬁcation (Kamimura et al., 2001, 2006;
Sakurai et al., 2001, 2005; Sugaya et al., 2008), the prospect that 6-O
sulfation plays a role in UB branching morphogenesis was investigat-
ed. Since three isoforms of glucosaminyl 6-O sulfotransferases exist
(Hs6st 1–3) and, to date, knockouts of these genes have shown no
kidney defects (Habuchi and Kimata, 2010), we examined the role of
6-O-desulfated (de6OS) heparin on UB branching morphogenesis in
vitro using cultured embryonic kidneys and cultured isolated UB.
Embryonic kidneys were isolated at e13 and were cultured in
the absence or presence of varying concentrations of 6OS-depleted
heparin added to standard media (Fig. 2). As previously described
(Shah et al., 2010), heparin or desulfated heparin compounds added
to the growth media will act as a sponge “absorbing” heparin-binding
growth factors that may be important to speciﬁc morphogenetic
processes. For example, heparin, a highly sulfated form of HS which
binds a large number of growth factors with high afﬁnity, would be
expected to “soak up” multiple growth factors interacting with 2-O
sulfated, 6-O sulfated and other moieties in the media thus limiting
their access to the developing kidney. Thus as expected, addition of
heparin to cultures of the whole embryonic kidneys severely impaired
their growth and development (Figs. 2A and D). On the other hand, if a
speciﬁcally desulfated heparin compound (i.e., 6OS-depleted heparin)
is added to the media, and growth factors are present in the mediawhich require this particular sulfation modiﬁcation for interaction
with heparin, then these growth factors will not bind to this de-
sulfated heparin and thus will still be free in the media to modulate
growth and development of the cultured kidney. Therefore, if the
growth and development of the cultured kidney is not as perturbed in
the presence of a de-sulfated heparin (compared to “normal”
heparin), then this particular sulfation modiﬁcation of HS would be
implicated, albeit indirectly, as potentially important in the binding
and/or modiﬁcation of the activity of growth factor(s) and/or
morphogenetic molecules involved in kidney development.
We and others have previously shown that the addition of heparin
to the media of cultured embryonic kidneys inhibits branching
morphogenesis at a concentration of 10 μg/ml and higher (Davies
et al., 2003; Shah et al., 2010). In our recent study, it was found that
addition of 2OS-depleted heparin (heparin in which sulfates have
been removed from the 2-O position, but sulfations at other positions
such as 3-O and 6-O are still present) did not signiﬁcantly impair
embryonic kidney growth at the same concentration (Shah et al.,
2010). Thus growth factors that require HS to be sulfated at the 2-O
position for binding to heparin were still free in media and were able
to stimulate growth of the cultured kidney (while those that require
3-O or 6-O sulfation would be “soaked up” by the 2OS-depleted
heparin). These results demonstrated the importance of 2OS HS
modiﬁcations in the binding and/or modulation of growth factors that
stimulate kidney development (Shah et al., 2010). In the studies
presented here, titration with 6OS-depleted heparin revealed that a
concentration of 10 μg/ml of 6OS-depleted heparin (no 6-O sulfation,
but other sulfations still present) did not signiﬁcantly perturb
embryonic kidney growth (MM induction and UB branching;
Fig. 2A). Unexpectedly, even at a de6OS concentration of 100 μg/ml,
overall UB branch architecture (the formation of clearly discernible
tips and stalks), while perturbed, was largely similar to control
(Fig. 2B, middle panel), although tip number was reduced. This is in
contrast to both heparin, which at a 10-fold lower concentration
(10 μg/ml) almost completely inhibited branching morphogenesis
and kidney development (Fig. 2A) and 2OS-depleted heparin which at
23M.M. Shah et al. / Developmental Biology 356 (2011) 19–27100 μg/ml resulted in severely malformed kidneys (data not shown;
(Shah et al., 2010)). Since heparin and 2OS-depleted heparin both
possess 6-O sulfated moieties (and thus deplete the organ culture of
growth factors which bind to 6-O sulfated HS, but not those which
bind to 2-O sulfated HS), and de6O heparin still possesses 2-O sulfated
moieties (and thus would deplete the organ culture of growth factors
which bind to 2-O sulfated HS, but not those which bind to 6-O
sulfated HS), these results indicate that HS 6-O sulfation is relatively
more important than is HS 2-O sulfation in the binding and/or
modulating the activity of growth factors speciﬁcally involved in UB
branching. This is because in the presence of 6OS-depleted heparin
those growth factors which require HS 6-O sulfation for binding will
not bind the exogenous 6OS-depleted heparin and remain free to
stimulate kidney development.
Isolated UB branching also depends largely on 6-O sulfation
To test the notion that HS 6-O sulfation was important in the
binding of growth factors involved in UB branching, we performed
similar titration studies on cultured isolated UBs. Similar to the whole
organ culture studies above, isolated UBswere cultured in the absence
or presence of either heparin or 6OS-depleted heparin. Heparin
clearly inhibited isolated UB branching in a dose-dependent fashion
(Fig. 3A). In fact, in the presence of heparin, the cultured UB lost the
distinction between stalks and tips (Fig. 3B, far left panel) and became
more amorphous (Fig. 3B, middle panel) and generally proliferative
(vs. the control isolated UB that mainly proliferates at the tips; results
not shown). Consistent with our recent study (Shah et al., 2010) and
similar to heparin, 2OS-depleted heparin (which is still sulfated at the
6-O position and thus will bind growth factors in the media which
require 6-O sulfated HS, but not those which require 2-O sulfated HS)A
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Fig. 3. Effects of 6OS-depleted heparin on isolated ureteric bud (UB) branching.
A: Graphical analysis of the average number of UB tips as a percentage of control when
cultured in the presence of varying concentrations of heparin or 6OS-depleted heparin
(hatched bars indicate results for isolated UBs cultured with 2OS-depleted heparin;
historical data from (Shah et al., 2010) shown for comparison). Mean±SD, nN3,
*pb0.05 compared to control. B–D: Phase-contrast photomicrographs of isolated UBs
cultured in the absence (B, control) or presence of 50 μg/ml heparin (C) or 6OS-
depleted heparin (D) demonstrating the loss of distinct UB tips and stalks that occurs in
with heparin.also inhibited UB branching in a dose dependent fashion (Shah et al.,
2010) (Fig. 3A, shaded bars); however, addition of exogenous 6OS-
depleted heparin (which is still sulfated at the 2-O and 3-O positions
but not at the 6-O position and thus will not bind growth factors
which require 6-O sulfated HS leaving them free in the media) had
signiﬁcantly less inhibitory effect on the growth and branching of the
isolated UB at 10 μg/ml, the dose at which both heparin (which is
sulfated at the 2-O, 3-O and 6-O positions) and 2OS-depleted heparin
(which is sulfated at the 3-O and 6-O positions, but not the 2-O
position) signiﬁcantly inhibited these processes (Fig. 3A). In fact, even
at 50 μg/ml 6OS-depleted heparin reduced branching by only ~25%
compared to a greater than 50% reduction induced by 2OS-depleted
heparin and an 80% reduction in the presence of heparin compare to
the 1 mg/ml condition (Fig. 3A). This result supports the notion that
the pattern of HS sulfation is critical to UB branching morphogenesis
and that, overall, 6-O sulfation likely plays a key role in regulating UB
branching morphogenesis via growth factor binding.
Growth factors that stimulate UB branching require HS 6-O sulfate
moieties for high afﬁnity binding
Taken together with our recent study (Shah et al., 2010), these
ﬁndings seem to indicate that for those growth factors modulating UB
branchingmorphogenesis 6-O sulfated HS aremore critical than those
interacting with 2-O sulfated HS. To further assess this, MM
conditioned media (BSN-CM), media that stimulates isolated UB
branching (Qiao et al., 1999a, 2001; Sakurai et al., 2001, 2005), was
fractionated over either a heparin, a de2OS or a 6OS-depleted heparin
column. The bound factors were eluted using increasing NaCl
concentrations and the fractions were assayed for morphogenetic
activity using the isolated UB branching assay (Bush et al., 2004;
Sakurai et al., 2001, 2005). Consistent with previous fractionation
studies, the peak morphogenetic activity was found to elute from the
heparin column starting at a NaCl concentration of 0.94 M (Figs. 4g
and h) (Bush et al., 2004; Sakurai et al., 2001, 2005). However, when
BSN-CM was fractionated over a 2OS-depleted heparin column (i.e.,
6OS sulfation still present), this peak stimulatory activity eluted from
the column at a NaCl concentration of 0.62 M, a signiﬁcant downward
shift in mobility (Figs. 4k and l). When fractionated over a 6OS-
depleted heparin column (i.e., 2OS sulfation still present) the elution
fraction was shifted even further downward to 0.27 M (Fig. 4q). Since
lower salt concentrations were needed to elute the bound proteins
from the de6OS column (which still possess 2-O sulfated moieties)
than from the de2OS or heparin columns (which still possess 6-O
sulfated moieties), this indicates that the branch-stimulating factors
present in BSN-CM bind with higher afﬁnity to the 6-O sulfate moiety
of HS than they do to the 2-O moiety. In support of this notion,
signiﬁcant branching activity was also seen in the ﬂow-through
fraction from the de6OS column which was not seen with the other
columns (Fig. 4o). This suggests that one or more of the branch
stimulating factors present in BSN-CM actually have lower afﬁnity for
heparin lacking 6-O sulfation modiﬁcations leading to decrease or no
binding to the column.
We then sought to identify the factor that might rely upon the 6-O
sulfation modiﬁcation by probing for the known branching morpho-
gens present in BSN-CM in the various fractions. Pleiotropin (PTN)
and heregulin (HRG) have both been isolated from BSN-CM as potent
stimulators of isolated UB branching (Sakurai et al., 2001, 2005). PTN
and HRGwere found in the fractions that correlated to peak branching
activity in all three columns (Figs. 5A and B). Similarly, we found that
puriﬁed GDNF and FGF1, necessary branching factors that are added
to BSN-CM in the isolated UB assay, also elute at similar salt
concentrations (Figs. 5C and D). These same growth factors were
also found in the ﬂow-through fraction collected from the de6O
heparin column (data not shown), indicating decreased binding
afﬁnity of the known branch-stimulating factors in the absence of 6-O
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Fig. 4.Morphogenetic activity of heparin and de2OS and de6OS column fractions. Phase contrast photomicrographs of isolated ureteric buds (UB) cultured in either whole BSN-CM
(a), DMEM/F12 (b) or puriﬁed fractions eluted from the columns (c–t). Isolated UBs cultured in whole BSN-CM (a, positive control) are large and have distinct stalks and tips while
UBs cultured in DMEM/F12 alone (b, negative control) display little growth or branching. Isolated UBs cultured in puriﬁed fractions of BSN-CM run over the heparin column (c–h),
2OS-depleted heparin column (i–n) or 6OS-depleted heparin column (o–t) demonstrate the presence of branch and growth promoting factors. The elution proﬁles demonstrate a
progressive downward shift of binding afﬁnity of stimulatory activity suggesting that HS 6-O sulfation is necessary for high afﬁnity binding. Of note, robust branch stimulatory
activity is detected in the ﬂow-through fraction of the de6OS column (o), but not in the heparin (c) or de2OS (i) columns, indicating a lack of binding to the de6OS column despite the
presence of other sulfation modiﬁcations.
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Fig. 5. Known branching morphogens have stronger binding afﬁnity to 6-O sulfate moieties over 2-O sulfate moieties. Western blots of the various fractions from the columns
demonstrate that the stimulatory activity corresponds to presence of pleiotrophin (A) and heregulin (B), known potent branching morphogens (Sakurai et al., 2001, 2005). When
puriﬁed growth factors, FGF1 (C) and GDNF (D) are run over the columns, similar to PTN and HRG, there is a progressive downward shift in binding afﬁnity from the heparin column
to the 2OS-depleted heparin column to the de6OS column, demonstrating that 6-O sulfate residues are required for high afﬁnity binding.
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Heparan Sulfate
Requirement
UB Branching Morphogenesis
6OS-HS > 2OS-HS
MM-derived nephron formation
2OS-HS> 6OS-HS
Fig. 6. Diagram illustrating the relative importance of 2O-sulfated HS versus 6O-
sulfated HS in the major morphogenetic processes critical to kidney development.
Together with our earlier study (Shah et al., 2010), data suggest that 2O-sulfated HS
have greater importance in MM-derived nephron formation, while 6O-sulfated HS
appear to have greater importance in UB branching morphogenesis.
25M.M. Shah et al. / Developmental Biology 356 (2011) 19–27sulfation. It is also possible that, yet to be identiﬁed, factors which
strictly require 6-O sulfation are also present in the ﬂow-through as
demonstrated by the signiﬁcant activity in the ﬂow through fraction.
Nevertheless, taken together, there clearly is a greater afﬁnity for 6-O
sulfation over 2-O sulfation for many of the branching-stimulating
factors.
Discussion
It is believed that spatio-temporally controlled microenviron-
ments of HSPGs modulate a variety of growth factor-mediated
morphogenetic events during UB branching morphogenesis from
branch point formation to stalk elongation (Bush et al., 2004;
Sampogna and Nigam, 2004; Shah et al., 2004, 2010; Steer et al.,
2004). These events likely occur through regulated growth factor-
growth factor receptor binding, the speciﬁcity of which is dictated by
the HS moieties. The roles for HSPGs in the control of morphogen
distribution and signaling during Drosophila development have been
well established, and a number of genetic and in vitro analyses have
demonstrated the critical importance of HS moieties for HSPG
function during developmental patterning (Han et al., 2004; Nakato
and Kimata, 2002; Takei et al., 2004). The involvement of HS in the
creation of morphogen gradients is not without precedent as HSPGs
have been shown to be involved in both Dpp and Wingless
morphogen gradient formation in Drosophila (Akiyama et al., 2008;
Kleinschmit et al., 2010). This is supported by biochemical data
demonstrating that HS plays a critical role in the assembly of the
FGF-FGFR complex such that certain FGF-FGFR interactions are
dependent upon the level of HS O-sulfation (Jastrebova et al., 2006),
while others appear to be dependent upon the speciﬁc sulfation
pattern (Guimond et al., 1993; Ostrovsky et al., 2002). However,
evidence that heparan sulfates are similarly involved in mammalian
organ patterning has been difﬁcult to obtain; although the hypothesis
that stages of organogenesis in branching epithelial organs like the
kidney has been discussed (Shah et al., 2004; Sampogna and Nigam,
2004; Nigam and Shah, 2009). In an effort to better understand the
general role of HS in mammalian organogenesis and speciﬁcally in
kidney branching morphogenesis, we employed a variety of exper-
imental techniques to elucidate how UB-derived HS might function in
the binding of growth factors important to UB branching.
In this study, it was found that 1) while a modiﬁed in situ LACE
assay demonstrated the presence of endogenous HS along the length
of the UB, depletion of endogenous HS with heparitinase suggested a
role for HS in limiting growth factors to speciﬁc regions of the UB (i.e.,
tip vs. stalk), 2) culture of whole embryonic kidneys in the presence of
variably sulfated heparins (i.e., heparin, de2OS-heparin and de6OS-
heparin) suggested a speciﬁc role for 6-O sulfatedHS in the growth and
development of the embryonic kidney, particularly in UB branching
morphogenesis, 3) treatment of the isolatedUBwith the same variably
sulfated heparinoids demonstrated a dependence of branching
morphogenesis on the presence of 6-O sulfation, providing further
evidence of a role for this HS modiﬁcation in branching, and 4)
fractionation of the BSN-conditioned medium (a demonstrated UB
branch promoting growthmedia) indicated that known UB branching
morphogens (i.e., pleiotrophin, heregulin, FGF1 and GDNF) have a
higher afﬁnity for 6-O sulfated heparin. Taken togetherwith our recent
ﬁnding in the Hs2st knockout mouse (Shah et al., 2010), variable
sulfation of HS clearly plays a role in the regulation/modulation of
kidney development. In particular, the development and differentia-
tion of theMM into the tubular nephronappears to bemore dependent
upon 2OSmodiﬁed HS, while growth and branching of the UB requires
6OS modiﬁed HS (Fig. 6).
We have previously shown that the defect underlying the renal
agenesis phenotype in mice with an Hs2st null genotype is primarily a
failure of MM induction (Shah et al., 2010). Given the dependency of
MM induction on a speciﬁc HS sulfation pattern, and the existingbiochemical data, it seems likely that growth factors which stimulate
UB branching may also demonstrate a strong dependency upon a
speciﬁc HS sulfation pattern. Our ﬁnding that factors that stimulate UB
branching are particularly dependent upon HS 6-O sulfation for high
afﬁnity binding is consistent with this hypothesis. However, unlike
mesenchymal induction, there appears to be more ﬂexibility in the HS
sulfation requirements for UB branching factors such that these
factors, which include GDNF, PTN and HRG, still show signiﬁcant
binding afﬁnity to 2OS-depleted heparin. This ﬂexibility in HS
requirement may be a mechanism through which morphogen
gradients form: the strongest concentration of morphogen is in
those areas in which the HS-growth factor binding is most avid.
The ﬁnding that many UB branching factors avidly bind 6-O sulfated
HSmayalso be amechanism for resiliency in thebranchingprogram.We
have previously hypothesized that UB branching itself is buffered by
many redundant growth factor-growth factor receptor combinations as
evidenced by the lack of intermediate UB branching phenotypes (Nigam
and Shah, 2009; Sampogna andNigam, 2004; Nigam and Shah, 2009). In
other words, the predominant renal phenotypes are fairly dichotomous
—either the kidney forms in totality or kidney agenesis occurs; among
clinical case reports and knockout studies, to our knowledge, there are
no reports of kidneys forming with under 100 nephrons. This lack of
intermediate phenotype may be due to the ability of HS to retain a
number of redundantbranch stimulatory factors in thevicinity of theUB.
It seems plausible that the HS-growth factor interaction also
determines the morphogenetic outcome of certain growth factors
such that a growth factor can induce a variety of different mor-
phogenetic events. Studies in submandibular gland morphogenesis
have shown that depending on the HS sulfation pattern, FGF10 was
able to induce either end bud expansion or duct elongation (Patel
et al., 2008). In addition, a recent study demonstrated a clear re-
quirement for 6-O sulfated HS in the Fgf10-Fgfr2b signaling critical for
lacrimal gland branching morphogenesis and development (Qu et al.,
2011), while double mutants of Hs2st/Hs6st displayed a complete lack
of lacrimal gland development and a loss of FGF-mediated Erk
signaling (Qu et al., 2011). Here, the ﬁnding that heparin can change
the phenotype of an isolated UB stimulated by FGF1 from a branching
structure with clear tips and stalks to an amorphous UB (Fig. 3) with a
phenotype that resembles an isolated UB stimulated by FGF7 (Qiao
et al., 2001) (perhaps through changes in FGFR2IIIb activity
(LaRochelle et al., 1999; Reich-Slotky et al., 1994)), suggests similar
functional redundancy in UB branching morphogenesis. Thus, one can
envision that depending on the sulfation status of endogenous HS, a
variety of factors could result in the formation of stalks vs. tips, adding
26 M.M. Shah et al. / Developmental Biology 356 (2011) 19–27functional redundancy to the branching program above and beyond
growth factor redundancy.
MM induction, which appears to be dependent upon very speciﬁc
factors, has a strong dependence upon 2-O sulfation (Shah et al.,
2010), and it may be that in sites of reciprocal induction, critical areas
for nephron formation, a more stringent requirement of HS sulfation
exists to ensure proper spatiotemporal activity of certain growth
factors or other molecules. It is conceivable then, that the ﬁne-tuning
of growth factor binding along various points of the branching UBmay
occur through the type of mechanism described here. For a variety of
stimulatory factors that induce growth and branching, there is
ﬂexibility in the HS requirement in order to diffusely retain such
factors near the branching UB but there may be a stringent
requirement for speciﬁc sulfation modiﬁcations in areas that are
critical for growth factor localization/activation (i.e. tip).
In total, these results outline a very dynamic role for variably sulfated
HS in modulating UB branching morphogenesis: it acts to localize
growth factor-growth factor receptor activity to certain regions; varying
binding afﬁnities of the same growth factor to 2-O vs 6-O sulfated HS
may assist in gradient formation; 6-O sulfated HS avidly binds a variety
of stimulatory growth factors that can buffer growth factor mutations;
depending on theHS sulfation pattern, a single growth factor can have a
variety of morphogenetic outcomes therefore adding another layer of
redundancy to the branching program. Although the complexity of
patterning in an organ such as the kidney is seemingly vast, these
studies demonstrate how HSPGs are central to the modulation of
growth factor activity along the branching UB (Shah et al., 2004;
Sampogna and Nigam, 2004; Nigam and Shah, 2009). While the exact
growth factor-HS interactions are yet to be elucidated, and there is likely
to be signiﬁcant overlapping and redundant interactions, it is becoming
clear that HSPG-mediated control of morphogen activity provides the
“ﬁne tuning” necessary to instruct the complex interactions which
result in the development of a speciﬁc organ.
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